image
Viking Therapeutics, Inc. VKTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 49.58
-7.45 %
$ 5.52 B
Market Cap
-53.89
P/E
BALANCE SHEET
368 M ASSETS
118.65%
Growth Rates
1Year 118.65%
3Years 12.84%
5Years 4.04%
7Years 58.70%
10Years 114.30%
20.1 M LIABILITIES
-13.51%
Growth Rates
1Year -13.51%
3Years 18.19%
5Years 34.49%
7Years 17.49%
10Years 46.83%
348 M EQUITY
139.76%
Growth Rates
1Year 139.76%
3Years 12.56%
5Years 3.19%
7Years 71.32%
10Years 106.24%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Viking Therapeutics, Inc.
image
Current Assets 367 M
Cash & Short-Term Investments 362 M
Receivables 0
Other Current Assets 5.15 M
Non-Current Assets 1.26 M
Long-Term Investments 0
PP&E 1.13 M
Other Non-Current Assets 139 K
Current Liabilities 19.1 M
Accounts Payable 7.51 M
Short-Term Debt 648 K
Other Current Liabilities 11 M
Non-Current Liabilities 936 K
Long-Term Debt 936 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 55.5 36.6 26.4 29.1 8.4 24.8 9.0 3.1 0.8 0.8 0.2 0
Short Term Investments 306.6 118.9 175.7 219.3 267.3 276.7 11.6 10.1 13.3 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 5.1 11.6 8.4 7.7 0.4 0.3 1.3 1.6 2.2 17.8 K 0 0
Total Current Assets 367.2 167.0 210.5 256.1 283.5 302.1 21.9 14.0 15.2 0.8 0.2 0
PP&E 1.1 1.4 25 K 0.3 0.6 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.1 71 K 0.1 77 K 0.2 0.2 0.3 0.6 0.2 2.3 775 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 368.5 168.5 210.7 256.5 284.3 302.3 22.1 14.5 15.4 3.0 0.2 0
LIABILITIES
Accounts Payable 7.5 8.5 1.4 4.0 2.4 1.0 1.5 1.2 0.6 1.8 74.1 K 54 K
Short Term Debt 0.6 0.6 58 K 0.7 0.6 0 3.5 3.3 0 0.3 46.9 K 0
Other Current Liabilities 11.0 12.8 7.3 7.5 3.7 3.6 3.7 2.0 1.4 20.4 6.51 K 350
Total Current Liabilities 19.1 21.9 8.8 12.1 6.8 4.5 8.7 6.5 2.0 22.5 0.1 54.4 K
Long Term Debt 0.9 1.3 0 29 K 0.4 0 0 0 2.2 1.3 0.2 42.8 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 12 K 0 16.3 K 2.6 1.4 71.7 K 8.29 K
Total Liabilities 20.1 23.2 8.8 12.2 7.1 4.6 8.7 6.5 6.7 25.2 0.4 0.1
EQUITY
Common Stock 1 K 1 K 1 K 1 K 1 K 1 K 358 208 97 60 52 50
Retained Earnings (377.9) (292.0) (223.2) (168.2) (128.7) (102.9) (80.9) (60.3) (45.5) (22.1) (0.3) (0.1)
Other Accumulative Comprehensive Income/Loss (0.4) (1.1) (0.5) 54 K 12 K (0.4) 19.8 K 6.89 K 7.37 K 0 4.5 K 0
Total Equity 348.4 145.3 201.9 244.3 277.1 297.8 13.5 8.0 8.7 (22.1) (0.3) (0.1)
Total Liabilities and Equity 368.5 168.5 210.7 256.5 284.3 302.3 22.1 14.5 15.4 3.0 0.2 0
SHARES OUTSTANDING
Common Shares Outstanding 94.3 76.8 77.2 72.6 72.0 57.6 26.0 16.3 6.4 4.3 4.3 1.48 K